Elsulfavirine: First Global Approval.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1811, doi. 10.1007/s40265-017-0820-3
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2017 AND VI 77 AND IP 16
Results: 10
1
2
Glecaprevir/Pibrentasvir: First Global Approval.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1797, doi. 10.1007/s40265-017-0817-y
- By:
- Publication type:
- Article
3
Erratum to: Durvalumab: First Global Approval.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1817, doi. 10.1007/s40265-017-0826-x
- By:
- Publication type:
- Article
4
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1733, doi. 10.1007/s40265-017-0806-1
- By:
- Publication type:
- Article
5
Pharmacological Management of Gestational Diabetes Mellitus.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1723, doi. 10.1007/s40265-017-0807-0
- By:
- Publication type:
- Article
6
Raltegravir Once-Daily Tablet: A Review in HIV-1 Infection.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1789, doi. 10.1007/s40265-017-0827-9
- By:
- Publication type:
- Article
7
Pharmacological Management of Chronic Rhinosinusitis: Current and Evolving Treatments.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1713, doi. 10.1007/s40265-017-0803-4
- By:
- Publication type:
- Article
8
Overlapping Effects of New Monoclonal Antibodies for Severe Asthma.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1769, doi. 10.1007/s40265-017-0810-5
- By:
- Publication type:
- Article
9
Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1755, doi. 10.1007/s40265-017-0814-1
- By:
- Publication type:
- Article
10
Pemafibrate: First Global Approval.
- Published in:
- Drugs, 2017, v. 77, n. 16, p. 1805, doi. 10.1007/s40265-017-0818-x
- By:
- Publication type:
- Article